This study introduced a novel perspective by focusing on the complex relationship between E2F family members, survival outcomes, and relapse mechanisms in GBM patients after BVZ treatment, with a particular emphasis on the role of E2F8. This evidence concerns the gene E2F8 and glioblastoma.